Figure 1.

(A) Variation of P100 latency reduction (improvement) with patient age for eyes with a prolonged baseline latency (>118 m). Each data point represents an eye, and the model fit with 95% confidence interval is shown. (B) Treatment effect (bexarotene vs. placebo) from (A) as a function of age. The region to the left of the dashed line shows the age range at which there is a significant treatment effect with type 1 error rate (α) = 0.05. [Colour figure can be viewed at wileyonlinelibrary.com]